Concurrent prescribing of opioids and benzodiazepines is associated with increased risk of emergency department visits and overdose. Postpartum women commonly receive opioids for pain after delivery and are at risk for postpartum depression/anxiety. Although
Jun 2024
Substance Use Disorder Treatment Carve Outs in Medicaid Managed Care
Medicaid managed care organizations (MCO) play a major role in addressing the nation’s epidemic of drug overdose and mortality by administering substance use disorder (SUD) treatment benefits for over 50
Jan 2024
Medicaid Managed Care Prior Authorization For Buprenorphine Tied To State Partisanship And Health Plan Profit Status, 2018
Buprenorphine is among the most effective drugs for treating opioid use disorder, yet only a quarter of Americans who need it receive it. Requiring prior authorization has been identified as
May 2023
A Gateway to Misuse? Synthetic Opioid Mortality and the Rescheduling of Hydrocodone in the United States
Opioid-related overdose mortality in the United States continues to rise, with opioid mortality reaching an all-time high in 2022 with more than 110,000 drug poisonings. To address the continuing opioid
Apr 2016
A Systematic Review on the Use of Psychosocial Interventions in Conjunction With Medications for the Treatment of Opioid Addiction
Opioid use and overdose rates have risen to epidemic levels in the United States during the past decade. Fortunately, there are effective medications (ie, methadone, buprenorphine, and oral and injectable
Dec 2014
A Longitudinal Study of State Strategies and Policies to Accelerate Evidence-Based Practices in the Context of Systems Transformation
The study used mixed methods, in-depth, semistructured interviews and quantitative surveys. Interviews assessed state and provider strategies to accelerate implementation of EBPs. Statewide implementation of psychosocial interventions and MAT increased
Mar 2011
Adoption and Implementation of Medications in Addiction Treatment Programs
Little is known about the extent to which medications are being implemented as routine care in addiction treatment programs. This research describes medication adoption and implementation within the privately funded
